NL-OMON34871
Completed
Phase 4
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPT
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- hyperactive parathyroid glands
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 20
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Primary hyperparathyroidism due to a genetically confirmed MEN\-1 mutation
Exclusion Criteria
- •No MEN\-1 mutation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center
Recruiting
Not Applicable
Effectiviteit en veiligheid van behandeling met cinacalcet bij patiënten met primaire hyperparathyreoïdie door een MEN-I mutatie.MEN-1Primary HyperparathyroidismPrimair HyperparathyreoidieCinacalcetCaSRNL-OMON23587eiden University Medical CenterDutch MEN-1 Study Group30
Active, not recruiting
Not Applicable
Assess the stability / benefit of Cinacalcet treatment over conventional therapy based on bone metabolism, arterial stiffness and vascular calcification in advanced chronic renal failureBone's disorders and mineral metabolism and vascular involvementMedDRA version: 16.1Level: PTClassification code 10051753Term: Vascular calcificationSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]EUCTR2013-002270-52-ESHospital Universitari de Girona Dr.Josep Trueta
Completed
Not Applicable
Evaluation of cinacalcet on clinical outcome depending on serum PTH level in Japanese patients with SHPT:ECO studySecondary hyperparathyroidismJPRN-UMIN000002769Division of Kidney and Hypertension, Department of Internal Medicine,The Jikei University School of Medicine120
Completed
Not Applicable
Prospective Study on the effects of cinacalcet HCL on vascular calcification and parathyroid glands size in patients on maintenance hemodialysischronic kidney disease patients with hyperparathyroidism undergoing hemodialysisJPRN-UMIN000002628Division of Nephrology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine60